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ABSTRACT: Emerging evidence supporting chronic disease ﬁghting properties of rice bran has advanced the development of
stabilized rice bran for human use as a functional food and dietary supplement. A global and targeted metabolomic investigation of
stabilized rice bran fermented with Saccharomyces boulardii was performed in three rice varieties. Metabolites from S. boulardii-
fermentedricebranweredetectedbygaschromatography-massspectrometry(GC-MS)andassessedforbioactivitycomparedto
nonfermented rice bran in normal and malignant lymphocytes. Global metabolite proﬁling revealed signiﬁcant diﬀerences in the
metabolome that led to discovery of candidate compounds modulated by S. boulardii fermentation. Fermented rice bran extracts
fromthreericevarietiesreducedgrowthofhumanBlymphomascomparedtoeachvariety’snonfermentedcontrolandrevealedthat
fermentation diﬀerentially altered bioactive compounds. These data support that integration of global and targeted metabolite
analysis can be utilized for assessing health properties of rice bran phytochemicals that are enhanced by yeast fermentation and that
diﬀer across rice varieties.
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’INTRODUCTION
Stabilized rice bran is a unique whole food that naturally
contains protein, vitamins, minerals, complex carbohydrates,
phytonutrients, phospholipids, essential fatty acids, and more
than 120 antioxidants.
1 Dietary rice bran intake and rice bran
componentshavedemonstratedchronic disease ﬁghting activity,
particularly for protection against cardiovascular disease and
certain cancers.
2-8 We and others have shown that rice varieties
are not equal in content and composition of bioactive rice bran
components.
9,10 How these phytochemicals are altered by mi-
crobial fermentation and metabolism is an emerging area of
research that merits scientiﬁc investigation when assessing
bioactivity and health beneﬁts. A few studies have evaluated
rice bran as a dietary supplement or functional food
ingredient;
5,11-13 however, little is known about how chemical
content changes with and without fermentation.
Theyeast,Saccharomycescerevisiaevar.boulardii(S.boulardii),
has probiotic activity and is widely used as a dietary supplement
for intestinal disease prevention and treatment.
14-16 The spec-
trum of biomedical activities and food processing applications
reported with S. boulardii has signiﬁcantly grown over the past
decade and includes, but is not limited to, protection against
entericpathogens, modiﬁcationof lymphocyte proliferation, and
diﬀerential release of plant secondary metabolites from foods
such as wine, sourdoughand cheese.
17-19 Sacchromycesboulardii
has been shown to be beneﬁcial for modiﬁcation of food
components such as breakdown of dietary phytate and bioforti-
ﬁcation of folate to improve the nutritional value and health
propertiesoffood.
20,21ThehealthbeneﬁtofS.boulardiibothasa
probiotic and for fermented foods was recently reviewed, and a
meta-analysis of placebo-controlled treatment trials supports its
safety and eﬃcacy for protection against several types of
diarrhea.
16,22,23 Protection against speciﬁc enteric bacterial
pathogens by S. boulardii may, in part, be due to anti-inﬂamma-
tory actionsand eﬀects on immunity.
15,19,23 In vitro studies using
mammalian cell cultures have shown that S. boulardii modiﬁes
host cell signaling pathways associated with proinﬂammatory
responses, and that the mechanism may be based on blocking
activation of nuclear factor-kappa B (NF-κB) and mitogen
activated protein kinase (MAPK).
24,25 Inhibition of these cell-
signaling pathways is also an important mechanism for reducing
cancer cell growth. Rice bran components have been reported to
inhibit activation and promote apoptosis of malignant lympho-
cytes and to inhibit growth of intestinal cancers.
3,11,26,27 In this
report,weexaminedtheeﬀectsofS.boulardiifermentedricebran
across rice varieties on viability of normal human blood lympho-
cytes and B lymphoma in vitro. Rice bran chemical contents and
thecompoundsalteredbyfermentationhavenotbeenpreviously
assessed for eﬀects on human B lymphomas, and were assessed
using global and targeted metabolite proﬁling techniques.
A signiﬁcant lack of knowledge exists regarding the ability of
probiotics to alter the phytochemistry of rice bran for health
beneﬁts, and global metabolite proﬁling represents a novel
approach to detect changes in rice bran phytochemical content
due to fermentation without a bias toward certain chemical
classes. A metabolite proﬁling approach based on gas chroma-
tography-mass spectrometry (GC-MS) was recently used to
investigate time-dependent metabolic changes during the germi-
nationofrice,
28andmoretargetedstudieshavesoughttoidentify
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bioactive and volatile compounds from rice bran oil or in bran
polishedfromredandblackricevarieties.
9,29Branfromthreerice
varieties was hypothesized herein to vary in bioactive chemical
contents after fermentation with S. boulardii and to diﬀerentially
inhibit human B lymphoma viability.
’MATERIALS AND METHODS
ReagentsandCellCulture. Caffeicacid,p-coumaricacid,ferulic
acid, salicylic acid, β-sitosterol, and R-tocopherol standards were
purchasedfromSigma-Aldrich(St.Louis,MO).Saccharomycesboulardii
was isolated from the commercial probiotic, Proboulardi (Metagenics
Inc., San Clemente, CA), and confirmed by morphological tests.
Cultures were maintained on yeast nitrogen base (YNB) amended with
0.5% (w/v) ammonium sulfate and 2% (w/v) dextrose. Raji B lympho-
mas were purchased from American Type Culture Collection. Whole
blood from healthy volunteers was collected into 8 mL cell preparation
tubes(CPT)withsodiumcitrateasananticoagulent(BectonDickinson
VacutainerSystems,FranklinLakes,NJ).CPTtubeswerecentrifugedat
1500g for 30 min for separation and enrichment of normal human
peripheral blood lymphocytes (PBL). PBL were washed two times with
1  phosphate buffered saline solution prior to resuspension in cell
culture medium. Blood was obtained at Colorado State University
according to Institutional Review Board approved protocols. Raji B
lymphomas and freshly isolated normal PBL were cultured in RPMI
mediumsupplementedwith10%fetalbovineserum,2mM L-glutamine,
10 mg/mL penicillin, 10,000 IU/mL streptomycin, 25 mg/mL ampho-
tericin,1mMsodiumpyruvate,and1 MEMnonessentialaminoacids.
RiceBranCollectionandStorage. Threericevarietiesselected
for investigation were Neptune, Wells and the near-isogenic line, Red
Wells
30 (Table 1). Rice bran was provided as a generous gift from Dr.
Anna McClung at the United States Department of Agriculture, Rice
Research Center (Stuttgart, Arkansas). Bran was isolated by standard
milling process, heat stabilized at 110  C for 3 min, and stored at -
20  C.
S.boulardiiFermentation andMetabolite Extraction. Rice
bran, water and probiotic yeast fermentations were carried out using a
modification ofthe methodsdescribed in refs 31 and 32. Briefly, 1.6 g of
rice bran was added to 11.4 mL of sterilized water in the presence and
absenceofS.boulardiiconcentrationof6 10
5cellsmL
-1,andsamples
wereincubatedat37 Cfor24hwithgentleshaking(n=3).Metabolites
were extracted using two separate solvents: either (A) isopropanol:
acetonitrile:water (3:2:2) for metabolite profiling or (B) methanol:
water (80:20) for measuring bioactivity on lymphoma or peripheral
blood lymphocytes in vitro. Solvent A was used for metabolite profiling
and was previously shown to extract both lipids and organic acids.
33,34
SolventBwasusedtostandardizecellculturetreatmentsandconditions,
as a similar single-phase aqueous-alcohol solvent was previously used to
assess effects of rice bran compounds.
26,27 After 24 h of fermentation in
water, either isopropanol:acetonitrile or methanol was added to the
culture for final 3:2:2 or 80:20 ratios, respectively. Samples were
vortexed and incubated at room temperature for five minutes, and bran
material and yeast cells were pelleted using centrifugation (1500g) for
ten minutes followed by filtration. The supernatant was collected and
stored at -80  C until further chemical and biological analyses.
Gas Chromatography-Mass Spectrometry. Rice bran me-
tabolites were detected by transferring 500 μL of extract to a new tube
and dried usinga vacuum centrifuge. The extract was derivatized by first
adding 50 μL of a solution containing 20 mg/mL of methoxyamine
hydrochloride in pyridine and incubating at 37  C for two hours. Next,
50 μLo fN-methyl-N-trimethylsilyltrifluoroacetamide with 1% tri-
methylchlorosilane (MSTFA þ 1% TMCS) (Thermo Scientific) was
addedandthereactionwasincubatedat37 Cfor60min.Sampleswere
centrifugedat3000gfor5min,and80μLofthesupernatantwasusedfor
GC-MS analysis. Caffeic acid, coumaric acid, ferulic acid, salicylic acid,
β-sitosterol, and R-tocopherol standards (Sigma-Aldrich, St. Louis,
MO) were dissolved in an isopropanol/acetonitrile/water solution
(3:2:2), evaporated, and derivatized under identical conditions.
The derivatized samples were equilibrated to room temperature,
transferredtoa200μLglassinsert,andanalyzedusingaTraceGCUltra
coupled to a Thermo DSQ II scanning from m/z 50-650 at a rate of 5
scans/s in electron impact mode. Samples were injected at a 10:1 split
ratio, and the inlet and transfer line were held at 280  C. Separation was
achieved on a 30 m TG-5MS column (Thermo Scientiﬁc, 0.25 mm i.d.,
0.25 μm ﬁlm thickness) using a temperature program of 80  C for 0.5
min,thenrampedat15 Cperminuteto330 Candheldfor8min,ata
constant ﬂow of 1.2 mL per minute. A single feature or known
metabolite was deﬁned by a given metabolite’s retention time and mass,
and the peak area was used to determine the relative quantity of each
feature or known metabolite.
Cell Viability. Raji B lymphomas and normal peripheral blood
lymphocyteswereplatedtoadensityof2.5 10
5cellspermL.Ricebran
extracts were dried in a vacuum centrifuge and resuspended in cell
culture medium, and cells were incubated in the presence of rice bran
extract for 24 h. Cells were centrifuged at 1500g for 5 min, resuspended
in a solution consisting of cell culture medium and 1% resazurin sodium
salt, andincubated at37  C forone hour.Fluorescence was measured at
765 nm, and viability was expressed as percent fluorescence relative to
the vehicle control.
35,36
S. boulardii Growth on Rice Bran. Saccharomyces boulardii
cultures were maintained in YNB (MP Biomedicals, Solon, OH) with
0.5% ammonium sulfate and 2% dextrose at 37  C. A liquid growth
medium containing 5% rice bran and water was made with each rice
variety. S. boulardii was added to the rice bran/water mixture at a final
OD600 of 0.02 (approximately 6   10
5 cells mL
-1). Cultures were
incubated at 37  C and sampled at 24, 48, and 72 h. Yeast cells were
enumerated by drop plating serial dilutions on YNB plates to determine
total colony forming units (CFUs).
Statistical Analysis. Chromatographic peaks between 2 and 25
min were detected by GC-MS and aligned using MarkerLynx software
(Waters,Millford,MA,USA)witharetentiontimeerrorwindowof0.05
min. Masses used for analyses ranged between 50 and 650 m/z with a
mass error tolerance of 0.4 m/z. Multivariate statistical analysis was
performed using SIMCA Pþ (v 12.0, Umetrics, Ume
  a, Sweden). Mean
Table 1. Rice Varieties Assessed for Bioactivity of the Bran
trait Neptune Wells Red Wells
plant introduction ID PI 655959 PI 612439
yield high high high
grain type long medium medium
leaf type erect erect erect
pericarp brown brown red
sheath blight moderately susceptible moderately susceptible moderately susceptible
rice blast moderately resistant moderately susceptible moderately susceptible1864 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
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centering and pareto scaling were applied for all principal component,
partial least-squares, and orthoganol projection to latent structures
(OPLS) analyses. Each feature was analyzed independently in a linear
mixed-effects model to determine the significance and percent variance
attributed to fermentation (fixed effect), or variety and variety-
fermentation interactions (random effects). Significance was
Figure 1. Metabolite proﬁlingof rice bran from three varieties with and without fermentation by S. boulardii. (A) Principal component analysis (PCA)
ofbran extracts fromthree ricevarieties (Neptune, Wellsand RedWells) show diversity in metabolite proﬁles.Theﬁrst principal component separated
thethreevarieties,andthesecondcomponentwasmostlycomposedofvariationamongreplicateswithinasinglevariety.(B)Arepresentativeportionof
aG C -MS chromatograph showed change in metabolites in fermented rice bran. Neptune rice variety alone (top), S. boulardii extract alone (middle)
andbranfromNeptunevarietyfermentedwithS.boulardii(bottom).Somepeaksarepresentinonlyonesample,andothersarepresentinbothbutvary
in quantity, as indicated by arrows above diﬀerential peaks. (C) PLS-DA model of three varieties nonfermented (black shading) or fermented with S.
boulardii(white).Theﬁrstcomponentseparatedeachvarietyfromitsfermentedcounterpart,andthesecondcomponentseparatedNeptunefromWells
and Red Wells.1865 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
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determined with a P-value threshold of 0.05, and percent variation was
determined using the sum of squares partitions of each random effect
relative to the total sum of squares of the model. Fold changes due to
fermentation were calculated for each feature using the peak areas of
fermented divided by the nonfermented. Bioactive compounds were
comparedamongvarietiesbyone-wayANOVA(P<0.05),andz-scores
were calculated for metabolites from fermented varieties based on the
mean and standard deviation of the nonfermented control. Effects on
lymphoma viability and increased growth of S. boulardii on rice bran
varieties were determined using a one-way ANOVA and Tukey’s HSD.
Significant differences between treatments (rice bran varieties) and
controls (YNB) were confirmed by a Dunnet’s 2-tailed comparison.
ThesetestswereperformedusingRsoftware(v2.11.1),GraphPadPrism
(v 5.0, GraphPad Software, Inc., La Jolla, CA) and XLStat-Pro
(Addinsoft USA, New York, NY).
’RESULTS
Rice Bran Metabolome Differences among Rice Varieties
before and after Fermentation with S. boulardii. Bran from
three rice varieties (Table 1) was extracted for metabolite
profiling and analyzed by gas chromatography coupled to mass
spectrometry (GC-MS). The rice varieties Neptune and Wells
are U.S. semidwarf varieties, and Red Wells is isogenic to Wells
apart from a single deleted base pair in the proanthocyanidin
gene Rc. This mutation results in the production of red pigment
in the bran layer of the seed.
30 Principal component analysis was
used to elucidate varietal differences in the metabolome of
nonfermented rice bran (Figure 1A). Varietal differences were
largely explained by the first component (56%), and the second
component differentiated between biological replicates (14%).
Rice bran was then incubated in the presence and absence of S.
boulardii and metabolites were extracted and detected by GC-
MS.The GC-MSchromatograms ofnonfermented ricebran, S.
boulardii fermented rice bran, and S. boulardii extracts showed
unique differences among the treatments (Figure 1B). Partial
least squares discriminant analysis (PLS-DA) was used to detect
differences in the metabolome among all three varieties and with
or without fermentation with S. boulardii (Figure 1C). The first
two components of the PLS-DA model explained 66% and 19%
of the variation, respectively.
This model demonstrates the ability to apply metabolite-
proﬁling techniques to diﬀerentiate chemical contents of fer-
mented rice bran from nonfermented rice bran, irrespective of
the rice variety tested.
Rice Bran Metabolites Modulated by S. boulardii Fermen-
tation. S. boulardii fermentation induced changes in metabolite
content for all three varieties were determined by quantitative
analysisofpeakareasfrom10,260GC-MSderivedfeatures.For
Neptune,Wells,andRedWells,448,127,and311featuresvaried
duetofermentation,respectively(Student’sttest,P<0.05).The
meanpercentvarianceexplainedbythelinearmixedmodelforall
features was 14.8%. Genotype and genotype-fermentation
effects explained a mean of 10% and 4.8% of the total variation,
respectively.
A series of PLS-DA and OPLS models were applied to each
rice variety to determine metabolites with the most signiﬁcant
changes due to fermentation (Figure 2). The eﬀect of fermenta-
tion on each variety’s metabolome was explained by the ﬁrst
component in each PLS-DA model. OPLS analyses were con-
ducted to determine metabolites quantitatively altered by yeast
probiotic fermentation. Metabolites of interest contained p(1)
and p(corr) values greater than 0.02 and 0.8, respectively, and
were analyzed for quantitative diﬀerences between samples by
Figure 2. PLS-DA and OPLS models to determine metabolite variation induced by fermentation with S. boulardii. Each variety was independently
analyzed for metabolite diﬀerences induced by S. boulardii fermentation. (A) Neptune PLS-DA showed the metabolome diﬀers between unfermented
(black) andfermented(white) samples. (B)TheNeptune OPLSanalysis showedmetabolitesthat highlydiﬀerbased onfermentation, indicated by the
dashed box for quadrant 2 (nonfermented) and quadrant 3 (fermented). p(corr) values correspond to deviation across replicates, and p(1) values are
proportional to the quantity of metabolite. Wells (C and D) and Red Wells (E and F) also showed altered metabolite content induced by S. boulardii.1866 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
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fold-change due to fermentation and by Student’s t test (P <
0.05) (Table 2). Mass spectra of signiﬁcant peaks were screened
in the National Institute of Technology Standards metabolite
database for probable matches. Rice varieties diﬀered in candi-
date metabolites altered by S. boulardii fermentation and by
chemical classes. For the three varieties, there was wide variation
in both the relative quantities of metabolites increased and the
types of predicted metabolites. S. boulardii fermentation of rice
bran diﬀers with regard to variety and was next evaluated for
impact on anticancer properties of rice bran.
S. boulardii Fermented Rice Bran Extracts Differentially
Inhibit Lymphoma Viability. Polar rice bran extracts were
previously shown to inhibit tumor promotion of lymphoblastoid
B cells, and rice bran agglutinin inhibited growth of monoblastic
leukemia U937 cells.
26 Methanol-soluble metabolites from Nep-
tune rice bran were screened for dose dependent effects on
viability of normal human peripheral blood lymphocytes (PBL)
and malignant human B-cell lymphoma (Figure 3A). Viability
was measured by resazurin stain after 24 h of incubation with
fermented and nonfermented rice bran extracts. The rice bran
extracts did not affect the viability of normal PBL (Figure 3A). A
significant reduction in lymphoma viability was demonstrated at
the500μgmL
-1doseofNeptunericebranextract,whilethe125
and 250 μgm L
-1 were not significantly reduced from vehicle
control (Figure 3A). The 500 μgm L
-1 dose of rice bran extract
was next used to examine effects of both nonfermented and
fermented rice bran extracts across varieties on normal PBL and
lymphoma. None of the rice bran extracts altered the viability of
normal PBL (Figure 3B). The S. boulardii-fermented rice bran
significantly inhibited lymphoma viability compared to vehicle
controls for all varieties tested (Figure 3C). The nonfermented
Neptune rice bran extracts showed a 23% reduction in viability,
and S. boulardii-fermented Neptune rice bran extracts reduced
viability by 85% compared to control. At 500 μgm L
-1, un-
fermented extracts of Wells and Red Wells had no effect on
lymphoma viability relative to the control, however fermented
extracts inhibited viability by 75% and 51%, respectively
(Figure 3C). The percent reduction in viability differed among
varieties of the three fermented extracts (ANOVA, Tukey post
hoc, P < 0.05). The differential reduction in viability by fermen-
ted rice bran among rice varieties supports that variation in
metabolitecontentsasdetectedinFigure1maybeimportantfor
bioactivity. The isopropanol:acetonitrile:water (3:2:2) solvent
used for metabolite profiling of fermented bran extracts
(Figure 2) was also examined for effects on lymphoma viability,
however this solvent demonstrated suboptimal background
activity as a vehicle control and was therefore not utilized to
compare effects across rice varieties (data not shown).
S. boulardii Modulation of Bioactive Rice Bran Com-
pounds. Given the varietal differences in anticancer activity of
S. boulardii fermented rice bran extracts, a number of bioactive
rice bran compounds were selected for relative quantification.
Rice bran contains a number of metabolites with reported
anticancer effects, notably phenolics and phytosterols.
37-39
Salicylic, p-coumaric, ferulic, and caffeic acid, and also R-toco-
pherol and β-sitosterol were detected in nonfermented and
fermentedricebranfromeachofthethreevarietiesbycomparing
the initial GC-MS chromatograms to purchased standards
(Figure 4). Nonfermented extracts from Wells contained a
greater quantity of salicylic acid than both Red Wells and
Neptune (Figure 4A). Red Wells contained higher amounts of
ferulic acid than Neptune, and Neptune contained significantly
lessβ-sitosterolthanbothWellsandRedWells(ANOVA,Tukey
post hoc, P < 0.05). A z-score analysis was conducted to
determine significant changes in metabolite quantity due to
fermentation with S. boulardii, using nonfermented rice bran as
a control. The data shown in Figure 4C supports that S. boulardii
fermentation reduced the quantity of p-coumaric acid in Red
Wells, and increased ferulic acid in Neptune (Figure 4C).
Rice Bran As Sole Carbon Source for S. boulardii. The
ability of S. boulardii to utilize and quantitatively alter chemical
components of rice bran was confirmed by measuring its growth
on rice bran as a sole carbon source. Overnight cultures of S.
boulardii inoculated into medium containing 5% rice bran from
Table 2. Varietal Diﬀerences in Candidate Compounds Altered by S. boulardii Fermentation
compound class fold change after fermentation p-value
Neptune
galactose sugar -10.32 0.03
palmitic acid fatty acid -1.2 0.04
R-linoleic acid fatty acid -1.23 0.04
unknown disaccharide sugar 26.44 0.001
xylitol sugar-alcohol 14.79 <0.001
glucitol sugar-alcohol a <0.001
alanine amino acid 4.63 0.02
phosphoric acid mineral 2 <0.001
1,2,3-propanetricarboxylic acid organic acid 4.34 0.02
Wells
D-fructose sugar -6.38 0.005
ribitol sugar-alcohol b <0.001
linoleic acid methyl ester fatty acid 1.4 0.04
Red Wells
palmitic acid fatty acid a 0.03
unknown disaccharide sugar a <0.001
aMetabolite only present in fermented extracts.
bMetabolite only present in nonfermented extracts.1867 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
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each of the varieties grew significantly better than cultures
inoculated into YNB broth with dextrose as the primary carbon
source (Figure 5). In addition, S. boulardii cultures maintained
viability and cell numbers for 3 days on rice bran medium, while
the number of cells in the YNB cultures steadily declined. No
significant differences in the growth of S. boulardii were detected
among the three rice varieties (ANOVA, Tukey post hoc, P <
0.05).
’DISCUSSION
This study demonstrates the utility of integrating global and
targetedmetaboliteproﬁlingforanalysisofricebranphytochem-
icalsinthepresenceandabsenceofS.boulardiifermentation,and
has advanced our knowledge about how probiotic fermentation
ofricebrancanenhancethebioactivityofextracts.Metabolomics
is onestrategy used to measurethe widearray of phytochemicals
thataretypicallyevaluated inthe“free”formsfromfoodextracts,
as these small molecules dissolve quickly and are immediately
absorbed into the bloodstream. This high throughput, yet
sensitive, approach is also useful to assess the “bound” forms of
ricemolecules,whichareattachedtotheplantcellwallsandmust
be released by microbes during digestion before they can be
absorbed. These ﬁndings set the stage for developing
Figure 3. S. boulardii fermented rice bran inhibits lymphoma viability.
(A) Diﬀerent doses of nonfermented methanolic rice bran extracts
(Neptune) were added to normal human peripheral blood lymphocytes
(PBL) and Raji B lymphoma cultures for 24 h. Values are expressed as
the mean percent viable cells relative to the vehicle control ( SEM.
Extracts of nonfermented Neptune reduced lymphoma viability at 500
μgm L
-1 (Student’s t test, P < 0.05). (B) Fermented and nonfermented
extracts ofall three varieties at500 μgm L
-1 had no eﬀect on viability of
normal PBL. (C) Fermented and nonfermented extracts of all three
varieties at 500 μgm L
-1 diﬀerentially aﬀected lymphoma viability, as
measured by cell ﬂuorescence after the addition of resaruzin (ANOVA,
Tukey post hoc, P < 0.05). Signiﬁcance from vehicle control is
represented by an asterisk, and statistical groupings are denoted by
the letters a, b, and c.
Figure 4. Bioactive food components in rice bran with and without
S. boulardii fermentation. Relative quantiﬁcation of metabolites without
fermentation(A)andwithfermentation(B)wasbasedontheareaofthe
GC-MS chromatograph. Metabolites showing a signiﬁcant diﬀerence
by relative quantity and between two varieties were indicated by an
asterisk (ANOVA, Tukey post hoc, P < 0.05). Values are expressed as
mean peak area ( SEM. (C) z-score for metabolites from fermented
extracts using the nonfermented as a control. Signiﬁcant changes in
metabolitequantityareindicatedbyz-scorevaluesoutsideoftheshaded
region. Increased ferulic acid was detected in S. boulardii fermented
Neptune rice bran, and decreased p-coumaric acid was detected from
fermented Red Wells compared to nonfermented.1868 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
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metabolomics as a tool for investigating rice bran phytochemical
diversity and digestion by probiotics.
Metabolite proﬁles in this study showed variation among the
three U.S. rice varieties Neptune, Wells, and Red Wells
(Figure 1A, Table 1). The Neptune metabolite proﬁle separated
from both Wells and Red Wells. This cluster was expected given
the near-isogenic state of the “Wells” varieties and provided
strongrationaleforinvestigatingdiﬀerential bioactive properties.
Rice bran fermentation with the S. boulardii probiotic enhanced
metabolite diversity (Figure 1C), and showed rice varietal
diﬀerences in bran extract-mediated reduction of lymphoma
growth (Figure 3B). No apparent toxicity was demonstrated
for S. boulardii fermented rice bran on normal peripheral blood
lymphocytes. Candidate metabolites that were signiﬁcantly in-
creased postfermentation also diﬀered among the three varieties
(Table 2). The ability of S. boulardii to utilize rice bran as a sole
carbon source substrate for cellular metabolism and growth
(Figure 5) suggests that rice bran contains unique prebiotic
characteristics.Althoughnodiﬀerencesweredetectedamongthe
Neptune,WellsandRedWellsricevarietiestoincreaseprobiotic
growth, these ﬁndings warrant further investigation of rice bran
prebiotic components and the synergistic eﬀects of prebiotic/
probiotic combinations on human health. To our knowledge,
only two studies have examined distinct rice bran varieties for
diﬀerential anticarcinogenic activity.
27,28 Data from these studies
demonstrate that rice varieties with pigmented seed coat also
exhibit diﬀerential activity when compared to nonpigmented.
The ﬁndings presented in this report suggest that some of the
inconsistent results of past rice bran investigations on cancer cell
growth may be due to the rice variety tested and not just those
chemicals responsible for pigment.
Another plausible explanation for inconclusive data on rice
branisnotonlydiﬀerencesinmetabolitecontentamongvarieties
but also the inﬂuence of probiotics altering the bioavailability of
cancer-protective compounds in select tissues. The ability of
phenols, particularly ferulic, salicylic, caﬀeic, and p-coumaric
acids and R-tocopherol (a lipid-soluble antioxidant) found in
rice bran, to scavenge free radicals, alter enzymes, aﬀect bio-
chemical pathways, and interfere with gene expression has
attracted the attention of researchers in search of cancer-ﬁghting
agents.
21,29,30 The eﬃcacy of ferulic acid, which remains in the
bloodstreamlongerthanotherknownantioxidantsandtherefore
may provide more protection, is dependent on its bioavailability
and dosage.
31 However, plant phenols are often found in a
biologically unavailable form due to an ester-bond to cell wall
polysaccharides. Therefore, the optimal dose of rice bran re-
quiredtoachievecancer-ﬁghtinglevelsofferulicacidisunknown.
Humans and rats have been shown to release diferulic acid from
bran ﬁber using gastrointestinal esterases found in the large and
small intestines, thus enhancing the bioavailability of this
compound.
32 The data shown in Figure 4C supports that the
Neptunericevarietymayexhibithigherprobiotic-inducedferulic
acid release and bioavailability than the other two varieties, and
that consuming the whole food postfermentation with S. bou-
lardii may be a viable alternative for achieving enhanced levels of
this compound without losing the beneﬁts of the others. Yeast
cells typically only maintain viability for several hours after they
have reached stationary phase and depleted their carbon source.
OurresultsshowthatricebranmediumallowsS.boulardiicellsto
maintain viability over several days, suggesting that secondary
fermentationbytheyeastmaybeoccurringandmayfurtheralter
the phytochemical content of the rice bran (Figure 5). Thus, it
will be necessary to optimize fermentation times to advance our
understanding of the kinetics of rice bran phytochemical meta-
bolism and release by S. boulardii.
Emerging evidence supports additive and/or synergistic ef-
fects of rice bran components for protection against certain
cancers,
5,11,40,41 however few studies have examined diﬀerences
in phytochemical contents in commercially available rice vari-
eties. Our data support that many rice bran components were
fermented by the yeast probiotic (Figure 2) and these compo-
nents work together to enhance probiotic growth (Figure 5).
Onestudyexaminedayeastfermentationofricebranforchanges
in the stability, palatability, and nutritional status (carbohydrate,
methionine, calcium, and ash content) of the bran, but did not
address the alteration of potentially bioactive phytochemicals.
42
Given the evidence for cancer ﬁghting activities of rice bran
phytochemicals, the data presented herein support that S.
boulardii-fermented rice bran should be next tested for bioavail-
ability of bioactive components and for reducing lymphoma
viabilityinvivo.Chemopreventivesingleagentcompoundsfound
in rice bran include, but are not limited to, tocopherols, poly-
phenols, inositol hexaphosphate (IP6), nonstarchy polysacchar-
ides,γ-oryzanolandphytosterols.
2,4,43-45Ourmetaboliteproﬁle
analysis of fermented rice bran revealed extensive rice bran
chemical diversity, and can be used to further the identities of
novel combinations of bioactive compounds that display phyto-
chemical teamwork.
46,47 Whole rice bran consumption is un-
doubtedly recognized as important for providing more
comprehensive protection against cancer cells when compared
to supplementation withisolated ingredients, and the metabolite
proﬁling techniques and chemical analyses presented herein
support further interrogation of rice bran eﬀects on intestinal
microbeinteractionsaswellasprobioticgrowthandmetabolism.
The metabolomics strategy applied herein has advanced our
understanding of the health importance of rice bran phytochem-
icaldiversityinthepresenceandabsenceoffermentationandfor
disease ﬁghting activity. Single agent nutritional “magic bullets”
toooftenfailtoachievethehealthbeneﬁtsindicatedbycell-based
assays. Available methodologies have also limited the scientiﬁc
investigations of rice bran to these reductive approaches. By
utilizing global metabolomic proﬁling, we can now more holi-
stically approach complex mixtures of small molecules in rice
branandimprovestudieslinkingbioactivefoodcomponentsand
human health.
Figure 5. Rice bran enhances growth of S. boulardii. Rice bran from all
three rice varieties signiﬁcantly increased the growth of S. boulardii
compared to YNB medium alone after 24, 48, and 72 h. An asterisk
indicates diﬀerence in the quantity of yeast colonies compared to the
YNB control (one way ANOVA, Tukey post hoc, P < 0.05).1869 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
Journal of Agricultural and Food Chemistry ARTICLE
’AUTHOR INFORMATION
Corresponding Author
*AnimalCancerCenter,DepartmentofClinicalSciences,Color-
ado State University, Fort Collins, CO 80523-1620. E-mail: E.P.
Ryan@colostate.edu. Tel: 970-297-5301. Fax: 970-297-1254.
Funding Sources
The Shipley Foundation and NIH 5R03CA150070-2 supported
this work.
’ACKNOWLEDGMENT
We would like to thank Dr. Ming-Hsuan Chen and Dr. Anna
McClungfromtheUSDA-ARSRiceResearchUnitforsupplying
the bran from Neptune, Wells and Red Wells rice varieties.
’ABBREVIATIONS USED
GC-MS, gas chromatography-mass spectrometry;U.S., Uni-
ted States.
’REFERENCES
(1) Kahlon,T.S.RiceBran:Production,Composition,Functionality
and Food Applications, Physiological Beneﬁts. In Fiber Ingredients: Food
Applications and Health Beneﬁts; Cho, S. S., Samuel, P., Eds.; Taylor and
Francis Group, LLC: Boca Raton, 2009; pp 305-21.
(2) Cai, H.; Al-Fayez, M.; Tunstall, R. G.; Platton, S.; Greaves, P.;
Steward, W. P.; Gescher, A. J. The rice bran constituent tricin potently
inhibits cyclooxygenase enzymes and interferes with intestinal carcino-
genesis in ApcMin mice. Mol. Cancer Ther. 2005, 4 (9), 1287–92.
(3) Kannan,A.;Hettiarachchy,N.;Johnson,M.G.;Nannapaneni,R.
Human colon and liver cancer cell proliferation inhibition by peptide
hydrolysates derived from heat-stabilized defatted rice bran. J. Agric.
Food Chem. 2008, 56 (24), 11643–7.
(4) Kong,C.K.;Lam,W.S.;Chiu,L.C.;Ooi,V.E.;Sun,S.S.;Wong,
Y. S. A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in
human colorectal adenocarcinoma SW480 and sensitizes metastatic
SW620 cells to TRAIL-induced apoptosis. Biochem. Pharmacol. 2009,
77 (9), 1487–96.
(5) Phutthaphadoong, S.; Yamada, Y.; Hirata, A.; Tomita, H.;
Taguchi, A.; Hara, A.; Limtrakul, P. N.; Iwasaki, T.; Kobayashi, H.;
Mori,H.Chemopreventiveeﬀectsoffermentedbrownriceandricebran
against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung
tumorigenesis in female A/J mice. Oncol. Rep. 2009, 21 (2), 321–7.
(6) Kestin, M.; Moss, R.; Clifton, P. M.; Nestel, P. J. Comparative
eﬀectsofthreecerealbransonplasmalipids,bloodpressure,andglucose
metabolisminmildlyhypercholesterolemicmen.Am.J.Clin.Nutr.1990,
52 (4), 661–6.
(7) Kuriyan, R.; Gopinath, N.; Vaz, M.; Kurpad, A. V. Use of rice
branoilinpatientswithhyperlipidaemia.Natl.Med.J.India2005,18(6),
292–6.
(8) Wilson, T. A.; Nicolosi, R. J.; Woolfrey, B.; Kritchevsky, D. Rice
bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol
concentrations and aortic cholesterol ester accumulation to a greater
extent than ferulic acid in hypercholesterolemic hamsters. J. Nutr.
Biochem. 2007, 18 (2), 105–12.
(9) Sukhonthara, S.; Theerakulkait, C.; Miyazawa, M. Characteriza-
tion of Volatile Aroma Compounds from Red and Black Rice Bran.
J. Oleo Sci. 2009, 58 (3), 155–160.
(10) Heuberger,A.L.;L.,M.;Chen,M.H.;Brick,M.A.;Leach,J.E.;
Ryan, E. P. Metabolomic and Functional Genomic Analyses Reveal
Varietal Diﬀerences in Bioactive Compounds of Cooked Rice. PLOS
One 2010, 5 (9), e12195.
(11) Katyama, M.; Yoshimi, N.; Yamada, Y.; Sakata, K.; Kuno, T.;
Yoshida, K.; Qiao, Z.; Vihn, P. Q.; Iwasaki, T.; Kobayashi, H.; Mori, H.
Preventive eﬀect of fermented brown rice and rice bran against colon
carcinogenesis in male F344 rats. Oncol. Rep. 2002, 9 (4), 817–22.
(12) Koh, J. H.; Suh, H. J. Biological Activities of Thermo-tolerant
Microbes from Fermented Rice Bran as an Alternative Microbial Feed
Additive. Appl. Biochem. Biotechnol. 2009, 157 (3), 420–430.
(13) Koh, J. H.; Yu, K. W.; Suh, H. J. Biological activities of
Saccharomyces cerevisiae and fermented rice bran as feed additives.
Lett. Appl. Microbiol. 2002, 35 (1), 47–51.
(14) Zanello, G.; Meurens, F.; Berri, M.; Salmon, H. Saccharomyces
boulardii eﬀects ongastrointestinal diseases. Curr. Issues Mol. Biol.2009,
11 (1), 47–58.
(15) Czerucka, D.; Piche, T.; Rampal, P. Review article: yeast as
probiotics -- Saccharomyces boulardii. Aliment. Pharmacol. Ther. 2007,
26 (6), 767–78.
(16) Yan, F.; Polk, D. B. Probiotics as functional food in the
treatment of diarrhea. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9 (6),
717–21.
(17) Fleet, G. H. Yeasts in foods and beverages: impact on product
quality and safety. Curr. Opin. Biotechnol. 2007, 18 (2), 170–175.
(18) Jespersen, L. Occurrence and taxonomic characteristics of
strains of Saccharomyces cerevisiae predominant in African indigenous
fermented foods and beverages. FEMS Yeast Res. 2003, 3 (2), 191–200.
(19) Martins, F. S.; Nardi, R. M.; Arantes, R. M.; Rosa, C. A.; Neves,
M. J.; Nicoli, J. R. Screening of yeasts as probiotic based on capacities to
colonizethegastrointestinaltractandtoprotectagainstenteropathogen
challenge in mice. J. Gen. Appl. Microbiol. 2005, 51 (2), 83–92.
(20) Rekha, C. R.; Vijayalakshmi, G., Bioconversion of isoﬂavone
glycosidestoaglycones,mineralbioavailabilityandvitaminBcomplexin
fermented soymilk by probiotic bacteria and yeast. J. Appl. Microbiol.
(21) Sindhu, S. C.; Khetarpaul, N. Eﬀect of probiotic fermentation
on antinutrients and in vitro protein and starch digestibilities of
indigenously developed RWGT food mixture. Nutr. Health 2002, 16
(3), 173–81.
(22) Skovgaard, N. New trends in emerging pathogens. Int. J. Food
Microbiol. 2007, 120 (3), 217–24.
(23) de Vrese, M.; Marteau, P. R. Probiotics and prebiotics: eﬀects
on diarrhea. J. Nutr. 2007, 137 (3 Suppl. 2), 803S–11S.
(24) Dalmasso,G.;Cottrez,F.;Imbert,V.;Lagadec,P.;Peyron,J.F.;
Rampal, P.; Czerucka, D.; Groux, H.; Foussat, A.; Brun, V. Sacchar-
omycesboulardiiinhibitsinﬂammatoryboweldiseasebytrappingTcells
in mesenteric lymph nodes. Gastroenterology 2006, 131 (6), 1812–25.
(25) Chen, X.; Kokkotou, E. G.; Mustafa, N.; Bhaskar, K. R.;
Sougioultzis, S.; O’Brien, M.; Pothoulakis, C.; Kelly, C. P. Saccharo-
myces boulardii inhibits ERK1/2 mitogen-activated protein kinase
activation both in vitro and in vivo and protects against Clostridium
diﬃcile toxin A-induced enteritis. J. Biol. Chem. 2006, 281 (34),
24449–54.
(26) Nam, S. H.; Choi, S. P.; Kang, M. Y.; Koh, H. J.; Kozukue, N.;
Friedman, M. Bran extracts from pigmented rice seeds inhibit tumor
promotion in lymphoblastoid B cells by phorbol ester. Food Chem.
Toxicol. 2005, 43 (5), 741–745.
(27) Miyoshi, N.; Koyama, Y.; Katsuno, Y.; Hayakawa, S.; Mita, T.;
Ohta,T.;Kaji,K.;Isemura,M.ApoptosisInductionAssociatedwithCell
Cycle Dysregulation by Rice Bran Agglutinin. J. Biochem. 2001, 130,
799–805.
(28) Shu, X. L.; Frank, T.; Shu, Q. Y.; Engel, K. H. Metabolite
proﬁling of germinating rice seeds. J. Agric. Food Chem. 2008, 56 (24),
11612–20.
(29) Goﬀman, F. D.; Pinson, S.; Bergman, C. Genetic diversity for
lipid content and fatty acid proﬁle in rice bran. J. Am. Oil Chem. Soc.
2003, 80 (5), 485–90.
(30) Brooks, S. A.; Yan, W.; Jackson, A. K.; Deren, C. W. A natural
mutation in rc reverts white-rice-pericarp to red and results in a new,
dominant, wild-type allele: Rc-g. Theor. Appl. Genet. 2008, 117, 575–80.
(31) Sindhu, S. C.; Khetarpaul, N. Eﬀect of probiotic fermentation
on antinutrients and in vitro protein and starch digestibilities of
indigenously developed RWGT food mixture. Nutr. Health 2002, 16
(3), 173–181.1870 dx.doi.org/10.1021/jf1038103 |J. Agric. Food Chem. 2011, 59, 1862–1870
Journal of Agricultural and Food Chemistry ARTICLE
(32) SINDHU, S. C. a. N. K. Fermentation with one step single and
sequential cultures of yeast and lactobacilli: Eﬀect on antinutrients and
digestibilities (in vitro) of starch and protein in an indigenously
developed food mixture. Plant Foods Hum. Nutr. 2003, 58,1 –10.
(33) Palazoglu, M.; Fiehn, O. Metabolite identiﬁcation in blood
plasma using GC/MS and the Agilent Fiehn GC/MS metabolomics
RTL library. Agilent Application Note 2009, 5990–3638EN.
(34) Skogerson, K.; Harrigan, G. G.; Reynolds, T. L.; Halls, S. C.;
Ruebelt, M.; Iandolino, A.; Pandravada, A.; Glenn, K. C.; Fiehn, O.
ImpactofGeneticsandEnvironmentontheMetaboliteCompositionof
Maize Grain. J. Agric. Food Chem. 2010, 58 (6), 3600–10.
(35) Xiao, J.; Zhang, Y.; Wang, J.; Yu, W.; Wang, W.; Ma, X.,
MonitoringofCellViabilityandProliferationinHydrogel-Encapsulated
System by Resazurin Assay. Appl. Biochem. Biotechnol.
(36) Duarte, M.; Giordani, R. B.; De Carli, G. A.; Zuanazzi, J. A.;
Macedo,A.J.;Tasca,T.Aquantitativeresazurinassaytodeterminatethe
viability of Trichomonas vaginalis and the cytotoxicity of organic
solvents and surfactant agents. Exp. Parasitol. 2009, 123 (2), 195–8.
(37) Taniguchi, H.; Hosoda, A.; Tsuno, T.; Maruta, Y.; Nomura, E.
Preparation of ferulic acid and its application for the synthesis of cancer
chemopreventive agents. Anticancer Res. 1999, 19 (5A), 3757–61.
(38) Bouic, P. J. D.; Etsebeth, S.; Liebenberg, R. W.; Albrecht, C. F.;
Pegel, K.; Van Jaarsveld, P. P. Beta-sitosterol and beta-sitosterol gluco-
side stimulate human peripheral blood lymphocyte proliferation: Im-
plications for their use as an immunomodulatory vitamin combination.
Int. J. Immunopharmacol. 1996, 18 (12), 693–700.
(39) Piironen, V.; Lindsay, D. G.; Miettinen, T. A.; Toivo, J.; Lampi,
A.-M. Plant sterols: biosynthesis, biological function and their impor-
tance to human nutrition. J. Sci. Food Agric. 2000, 80 (7), 939–66.
(40) Mori,H.;Kawabata,K.;Yoshimi,N.;Tanaka,T.;Murakami,T.;
Okada,T.;Murai,H.Chemopreventiveeﬀectsofferulicacidonoraland
rice germ on large bowel carcinogenesis. Anticancer Res. 1999, 19 (5A),
3775–8.
(41) Hudson, E. A.; Dinh, P. A.; Kokubun, T.; Simmonds, M. S. J.;
Gescher, A. Characterization of Potentially Chemopreventive Phenols
inExtractsofBrownRiceThatInhibittheGrowthofHumanBreastand
Colon Cancer Cells. Cancer Epidemiol., Biomarkers Prev. 2000, 9, 1163–
70.
(42) Feddern, V.; Furlong, E. B.; Soares, L. A. d. S. Eﬀects of
fermentation on the physicochemical and nutritional properties of rice
bran. Ci^ enc. Tecnol. Aliment., Campinas 2007, 27 (4), 800–4.
(43) Takeshita, M.; Nakamura, S.; Makita, F.; Ohwada, S.; Miyamo-
to, Y.; Morishita, Y. Antitumor eﬀect of RBS (rice bran saccharide) on
ENNG-induced carcinogenesis. Biotherapy 1992, 4 (2), 139–45.
(44) Aoe, S.; Oda, T.; Tojima, T.; Tanaka, M.; Tatsumi, K.;
Mizutani, T. Eﬀects of rice bran hemicellulose on 1,2-dimethylhydra-
zine-induced intestinal carcinogenesis in Fischer 344 rats. Nutr. Cancer
1993, 20 (1), 41–9.
(45) Norazalina, S.; Norhaizan, M. E.; Hairuszah, I.; Norashareena,
M.S.Anticarcinogeniceﬃcacyofphyticacidextractedfromricebranon
azoxymethane-induced colon carcinogenesis in rats. Exp. Toxicol.Pathol
2010, 62 (3), 259–68.
(46) Adom, K. K.; Sorrells, M. E.; Liu, R. H. Phytochemical Proﬁles
and Antioxidant Activity of Wheat Varieties. J. Agric. Food Chem. 2003,
51 (26), 7825–34.
(47) Lila, M. A. From beans to berries and beyond: teamwork
between plant chemicals for protection of optimal human health. Ann.
N.Y. Acad. Sci. 2007, 1114, 372–80.